20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0 ..................... PRASTERONE. Abstracts Service Number (``CAS N/A ............................. CORTICORELIN. 53±46±3 ..................... METHANTHELINIUM BROMIDE. N/A ............................. DORLIMOMAB ARITOX. 53±73±6 ..................... ANGIOTENSINAMIDE. Number'') order. N/A ............................. FIBRINOGEN (125 I). 53±79±2 ..................... PUROMYCIN. N/A ............................. INSULIN DEFALAN. 53±84±9 ..................... NADIDE. SUMMARY: By act of Congress, the U.S. N/A ............................. MACROGOL ESTER. 53±86±1 ..................... INDOMETACIN. N/A ............................. POLYSORBATE. 53±89±4 ..................... BENZPIPERYLONE. Customs Service implemented the N/A ............................. SEVIRUMAB. 54±03±5 ..................... HEXOBENDINE. Pharmaceutical Agreement of the N/A ............................. SOMETRIBOVE. 54±05±7 ..................... CHLOROQUINE. General Agreements on Tariff and Trade N/A ............................. SOMETRIPOR. 54±30±8 ..................... CAMYLOFIN. N/A ............................. TENDAMISTAT. 54±31±9 ..................... FUROSEMIDE. (GATT) on January 1, 1995. A critical N/A ............................. THYMOSTIMULIN. 54±32±0 ..................... MOXISYLYTE. portion of the implementing legislation N/A ............................. TUVIRUMAB. 54±36±4 ..................... METYRAPONE. N/A ............................. UROFOLLITROPIN. 54±42±2 ..................... IDOXURIDINE. includes listings of the pharmaceuticals 50±02±2 ..................... DEXAMETHASONE. 54±49±9 ..................... METARAMINOL. and pharmaceuticals intermediates 50±06±6 ..................... PHENOBARBITAL. 54±64±8 ..................... THIOMERSAL. 50±07±7 ..................... MITOMYCIN. 54±80±8 ..................... PRONETALOL. covered by the treaty. These listings, 50±10±2 ..................... OXYPHENONIUM BROMIDE. 54±85±3 ..................... ISONIAZID. Tables 1 and 3 of the Pharmaceutical 50±11±3 ..................... METHARBITAL. 54±91±1 ..................... PIPOBROMAN. 50±12±4 ..................... MEPHENYTOIN. 54±92±2 ..................... IPRONIAZID. Appendix of the Tariff Schedule, consist 50±14±6 ..................... ERGOCALCIFEROL. 54±95±5 ..................... PENTETRAZOL. of an alphabetical listing of 50±18±0 ..................... CYCLOPHOSPHAMIDE. 55±03±8 ..................... LEVOTHYROXINE SODIUM. 50±19±1 ..................... OXYFENAMATE. 55±52±7 ..................... PHENIPRAZINE. pharmaceuticals and pharmaceutical 50±23±7 ..................... HYDROCORTISONE. 55±56±1 ..................... CHLORHEXIDINE. intermediates with corresponding CAS 50±24±8 ..................... PREDNISOLONE. 55±65±2 ..................... GUANETHIDINE. numbers. U.S. Customs and other 50±28±2 ..................... ESTRADIOL. 55±73±2 ..................... BETANIDINE. 50±29±3 ..................... CLOFENOTANE. 55±97±0 ..................... HEXAMETHONIUM BROMIDE. agencies have been receiving comments 50±33±9 ..................... PHENYLBUTAZONE. 55±98±1 ..................... BUSULFAN. from the public indicating that because 50±34±0 ..................... PROPANTHELINE BROMIDE. 56±04±2 ..................... METHYLTHIOURACIL. 50±35±1 ..................... THALIDOMIDE. 56±28±0 ..................... TRICLODAZOL. of the large number of products listed in 50±37±3 ..................... LYSERGIDE. 56±29±1 ..................... HEXOBARBITAL. the tables and the fact that the products 50±39±5 ..................... PROTHEOBROMINE. 56±40±6 ..................... GLYCINE. 50±44±2 ..................... MERCAPTOPURINE. 56±41±7 ..................... ALANINE. may be properly identified by several 50±47±5 ..................... DESIPRAMINE. 56±45±1 ..................... SERINE. different names, it is difficult to apply 50±48±6 ..................... AMITRIPTYLINE. 56±53±1 ..................... DIETHYLSTILBESTROL. 50±49±7 ..................... IMIPRAMINE. 56±59±7 ..................... FELYPRESSIN. the Pharmaceutical Appendix in a 50±50±0 ..................... ESTRADIOL BENZOATE. 56±72±4 ..................... COUMAFOS. significant number of instances. In 50±52±2 ..................... THIORIDAZINE. 56±75±7 ..................... CHLORAMPHENICOL. general, the public has indicated that 50±53±3 ..................... CHLORPROMAZINE. 56±84±8 ..................... ASPARTIC ACID. 50±55±5 ..................... RESERPINE. 56±85±9 ..................... LEVOGLUTAMIDE. products covered by the treaty are more 50±56±6 ..................... OXYTOCIN. 56±86±0 ..................... GLUTAMIC ACID. easily identified by their CAS numbers 50±57±7 ..................... LYPRESSIN. 56±87±1 ..................... LYSINE. 50±59±9 ..................... CEFALORIDINE. 56±94±0 ..................... DEMECARIUM BROMIDE. and that use of the Tariff Schedule 50±60±2 ..................... PHENTOLAMINE. 56±97±3 ..................... TRIMEDOXIME BROMIDE. would be greatly facilitated if a listing 50±65±7 ..................... NICLOSAMIDE. 57±08±9 ..................... ACEXAMIC ACID. 50±76±0 ..................... DACTINOMYCIN. 57±09±0 ..................... CETRIMONIUM BROMIDE. of the products in Tables 1 and 3 is 50±81±7 ..................... ASCORBIC ACID. 57±15±8 ..................... CHLOROBUTANOL. made available in CAS number 50±91±9 ..................... FLOXURIDINE. 57±22±7 ..................... VINCRISTINE. numerical order. 51±06±9 ..................... PROCAINAMIDE. 57±30±7 ..................... PHENOBARBITAL SODIUM. 51±12±7 ..................... NIALAMIDE. 57±41±0 ..................... PHENYTOIN. Accordingly, listed below are the 51±18±3 ..................... TRETAMINE. 57±42±1 ..................... PETHIDINE. products found in Table 1 and Table 3 51±21±8 ..................... FLUOROURACIL. 57±43±2 ..................... AMOBARBITAL. 51±24±1 ..................... TIRATRICOL. 57±44±3 ..................... BARBITAL. of the Pharmaceutical Appendix of the 51±26±3 ..................... THYROPROPIC ACID. 57±53±4 ..................... MEPROBAMATE. Harmonized Tariff Schedule which have 51±31±0 ..................... LEVISOPRENALINE. 57±57±8 ..................... PROPIOLACTONE. 51±41±2 ..................... NOREPINEPHRINE. 57±62±5 ..................... CHLORTETRACYCLINE. been arranged in CAS number order. 51±43±4 ..................... EPINEPHRINE. 57±63±6 ..................... ETHINYLESTRADIOL. This listing is neither intended to 51±52±5 ..................... PROPYLTHIOURACIL. 57±66±9 ..................... PROBENECID. change the legal intent of the 51±61±6 ..................... DOPAMINE. 57±67±0 ..................... SULFAGUANIDINE. 51±64±9 ..................... DEXAMFETAMINE. 57±68±1 ..................... SULFADIMIDINE. Pharmaceuticals Appendix as stated in 51±68±3 ..................... MECLOFENOXATE. 57±83±0 ..................... PROGESTERONE. the Tariff Schedule, nor is it intended to 51±71±8 ..................... PHENELZINE. 57±92±1 ..................... STREPTOMYCIN. 51±75±2 ..................... CHLORMETHINE. 57±94±3 ..................... TUBOCURARINE CHLORIDE. define or change U.S. Customs policy in 51±77±4 ..................... GEFARNATE. 57±96±5 ..................... SULFINPYRAZONE. enforcing the statute. Rather, the listing 51±79±6 ..................... URETHANE. 58±14±0 ..................... PYRIMETHAMINE. 51±83±2 ..................... CARBACHOL. 58±15±1 ..................... AMINOPHENAZONE. is intended to assist users of the Tariff 52±01±7 ..................... SPIRONOLACTONE. 58±18±4 ..................... METHYLTESTOSTERONE. Schedule to more quickly identify 52±24±4 ..................... THIOTEPA. 58±19±5 ..................... DROSTANOLONE. products which are covered by the 52±31±3 ..................... CYCLOBARBITAL. 58±22±0 ..................... TESTOSTERONE. 52±39±1 ..................... ALDOSTERONE. 58±25±3 ..................... CHLORDIAZEPOXIDE. statute. 52±43±7 ..................... ALLOBARBITAL. 58±32±2 ..................... DIPYRIDAMOLE. EFFECTIVE DATE 52±51±7 ....................